Synos Health®, the leading biopharmaceutical solutions organization, is proud to announce their strategic partnership with Equicare, leveraging proXimity™, a cloud-based software platform that expedites the movement of clinical trial data from multiple EHRs to sponsors’ EDCs. This cutting-edge technology promises to revolutionize the clinical trial data transfer process, providing sponsors with greater agility and accuracy.
Syneos Health is thrilled to announce a partnership with the proXimity platform, which will revolutionize clinical trials by automating sponsor data transfers from EHRs to EDCs. This collaboration is a major step toward accelerating the development of new therapies and treatments for patients, and demonstrates Syneos Health’s dedication to listening and responding to the needs of clinical sites.
At Syneos Health, we are passionate about providing the best possible experience for our customers. That’s why we are thrilled to partner with Equicare and use their proXimity platform to address common clinical trial challenges sites and sponsors face, such as data capture, timelines and quality control. We believe that this collaboration will help streamline data entry and management, resulting in more accurate data that will ultimately help bring new therapies to patients faster.
Say goodbye to time-consuming, error-prone manual data transcription for clinical trials. With proXimity’s automated process, transferring data from one system to another is a breeze. Not only does it save time, but it also helps to ensure accuracy and reduce transcription errors, making data transfers more efficient than ever before.
The proXimity software, while therapeutically agnostic, was first selected by NEXT Oncology – part of the Syneos Health Catalyst Site Program for phase I studies – as the exclusive tool to revolutionize clinical trial data management. By automating the transfer of clinical trial data from EHR to EDC systems, it drastically speeds up the performance of new therapies in clinical trials. This revolutionary platform now serves as a key tool for sponsors to gain access to their data and accelerate cancer research.
In a recent proof of concept exercise, NEXT Oncology used proXimity to transfer data from their EHR to the Syneos Health managed EDC database with remarkable results. Compared to manual data entry, the data transfer was a whopping five times faster, and with an unprecedented 0% error rate – compared to the usual 3.5% error rate! This groundbreaking technology is revolutionizing the data transfer process and promises to provide reliable, accurate, and speedy results.
At NEXT Oncology, we are excited to be leveraging proXimity to deliver data to our sponsors faster and with fewer errors. We anticipate that by 2023, all studies utilizing Medidata Rave as the EDC will benefit from the use of proXimity. We are proud to be working with Syneos Health in achieving our goal of bringing new therapies to cancer patients faster. Dr. Anthony Tolcher, MD, Medical Oncologist and co-founder of NEXT Oncology, is excited about the potential of this technology to revolutionize the way we conduct clinical trials.
About Syneos Health
At Syneos Health® (Nasdaq:SYNH), we understand the complexities of the biopharmaceutical industry, and we are committed to providing comprehensive solutions to help our customers succeed. By leveraging our unique clinical, medical affairs and commercial expertise, we create innovative strategies and outcomes tailored to today’s market realities.
We are an expert team of professionals from more than 110 countries, dedicated to helping our customers get life-saving treatments to patients faster. We utilize the latest technologies and advanced business solutions to get a deep understanding of patient and physician behaviors, market dynamics, and more. Our insights enable us to provide the best possible services and enable our customers to make the most of their resources. Together, we strive to make a difference in the lives of patients around the world.
At Syneos Health, we are committed to fostering a culture of diversity, equity and inclusion. Our priority is to ensure that our colleagues, customers, patients, communities and the environment are supported and cared for. We strive to create an atmosphere of inclusion, acceptance, and respect for all.